Evidence map›Paper›PMID 36625475›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2023

Effect of an obesogenic high-fat and high-sucrose diet on hepatic gene expression signatures in male Collaborative Cross mice.

Volodymyr P Tryndyak, Rose A Willett, Suresh K Nagumalli, Dan Li, Mark I Avigan, Frederick A Beland, Ivan Rusyn, Igor P Pogribny

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Volodymyr P TryndyakDivision of Biochemical Toxicology, Food and Drug Administration-National Center for Toxicological Research, Jefferson, Arkansas.
Rose A WillettDivision of Biochemical Toxicology, Food and Drug Administration-National Center for Toxicological Research, Jefferson, Arkansas.
Suresh K NagumalliDivision of Biochemical Toxicology, Food and Drug Administration-National Center for Toxicological Research, Jefferson, Arkansas.
Dan LiDivision of Bioinformatics and Biostatistics, Food and Drug Agency-National Center for Toxicological Research, Jefferson, Arkansas.
Mark I AviganOffice of Pharmacovigilance and Epidemiology, Food and Drug Administration-Center for Drug Evaluation and Research, Silver Spring, Maryland.
Frederick A BelandDivision of Biochemical Toxicology, Food and Drug Administration-National Center for Toxicological Research, Jefferson, Arkansas.
Ivan RusynDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas.
Igor P PogribnyDivision of Biochemical Toxicology, Food and Drug Administration-National Center for Toxicological Research, Jefferson, Arkansas.ORCID 0000-0002-5248-9843
National Center for Toxicological Research · USCenter for Drug Evaluation and Research · USTexas A&M University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonalcoholic fatty liver disease (NAFLD), the most prevalent chronic liver disease, is characterized by substantial variations in case-level severity. In this study, we used a genetically diverse Collaborative Cross (CC) mouse population model to analyze the global transcriptome and clarify the molecular mechanisms involved in hepatic fat accumulation that determine the level and severity of NAFLD. Twenty-four strains of male CC mice were maintained on a high-fat/high-sucrose (HF/HS) diet for 12 wk, and their hepatic gene expression profiles were determined by next-generation RNA sequencing. We found that the development of the nonalcoholic fatty liver (NAFL) phenotype in CC mice coincided with significant changes in the expression of hepatic genes at the population level, evidenced by the presence of 724 differentially expressed genes involved in lipid and carbohydrate metabolism, cell morphology, vitamin and mineral metabolism, energy production, and DNA replication, recombination, and repair. Importantly, expression of 68 of these genes strongly correlated with the extent of hepatic lipid accumulation in the overall population of HF/HS diet-fed male CC mice. Results of partial least squares (PLS) modeling showed that these derived hepatic gene expression signatures help to identify the individual mouse strains that are highly susceptible to the development of NAFLD induced by an HF/HS diet. These findings imply that gene expression profiling, combined with a PLS modeling approach, may be a useful tool to predict NAFLD severity in genetically diverse patient populations.

Indexed as

Non-alcoholic Fatty Liver DiseaseAnimalsCollaborative Cross MiceDiet, High-FatHumansLipid MetabolismLipidsLiverMaleMiceMice, Inbred C57BLSucroseTranscriptomeLipidsSucrosegene expression profilehigh-fat and high-sucrose dietlivernonalcoholic fatty liver disease

Identifiers

PMID36625475
PMCPMC10191133
OpenAlexW4313910187

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.